Corporate hospital major Apollo Hospitals Enterprise Ltd on November 11 said it would acquire for Rs.4.10 billion the remaining 50 percent stake in Apollo Gleneagles Hospitals Ltd, Kolkata held by Gleneagles Development PTE Ltd, Singapore.

In a regulatory filing, Apollo Hospitals said its Board has decided that the company would acquire 50 percent stake held by Gleneagles Development in the equal joint venture Rs 723 crore Apollo Gleneagles Hospitals. Consequent to this development, Apollo Gleneagles would become a 100 percent wholly owned subsidiary of the city-based Apollo Hospitals.

The acquisition is to be completed by December 15. Similarly, the Apollo Hospitals Board also approved acquisition of additional one percent equity stake in Medics International Life Sciences Ltd, an unlisted public limited company which runs a 330 bedded multi-speciality hospital in Lucknow, in which it already holds a 50 percent equity stake for a consideration of Rs 39.76 million.

Consequent to this, Medics International Life Sciences will become a subsidiary of the company. For the purposes of funding the acquisition of 50 percent stake in Apollo Gleneagles, Apollo Hospitals Board has also approved raising a sum of Rs 15 billion through issue of securities on a preferential basis and or through Qualified Institutional Placement (QIP) and also for any potential acquisitions, reduction of debt, for investments in technology upgradations and digital initiatives.